Pancreatic Cancer Research

ResearcherSheng Jing HospitalActive in the last 2 years

Baosheng Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6075-7919; OpenAlex author ID A5014624386. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2024: 2 papers · 2025: none · 2026: 1 paper

Papers 3

  1. RBM15-Mediated m6A Modification Regulates Proliferation and Migration of Pancreatic Cancer Cells via the lncRNA LINC01320/miR-1287-5p/FBXO11 Axis. First author DOI 10.4062/biomolther.2025.159↗
  2. HTF4 modulates the transcription of GID2 to promote the malignant biological behavior of pancreatic cancer. Co-author DOI 10.1016/j.pan.2024.08.008↗
  3. The DDX6/KIFC1 signaling axis, as regulated by YY1, contributes to the malignant behavior of pancreatic cancer. Co-author DOI 10.1096/fj.202400166r↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xin Deng · 1 shared paper, 2026 · strength 0.63
  2. Xiangpeng Meng · 2 shared papers, 2024 · strength 0.54
  3. Xin Deng · 1 shared paper, 2024 · strength 0.28
  4. Zhen Liu · 1 shared paper, 2024 · strength 0.28
  5. Xin Deng · 1 shared paper, 2024 · strength 0.26
  6. Jia Ma · 1 shared paper, 2024 · strength 0.26
  7. Wenyang Zhou · 1 shared paper, 2024 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.